Comparing to these findings, K3-HBc/CLT NCs in our study were expected to see further improvement in the efficacy for renal fibrosis, since tubular epithelial cells could synthesize and secrete varieties of bioactive molecules that drive interstitial inflammation and fibrosis [8, 36, 37]. The gene discussed is KRT88P; the disease is renal fibrosis.